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Background and purpose   In the city of Trondheim, Norway, 
diabetic lower-limb amputations accounted for one-third of all 
lower-limb amputations (LLAs). In an attempt to reduce this rate, 
a diabetic foot team was established in 1996. We present the inci-
dence of LLA in Trondheim as measured 10 years later. 
Patients and methods   In 2004–07, we registered all LLAs 
performed in Trondheim and then compared the data with previ-
ously published data from 1994–1997. From 1996 through 2006, 
we registered the activity of the diabetic foot team and we also 
registered the number of vascular procedures performed on citi-
zens of Trondheim from 1998 through 2006. 
Results   Comparing the two 3-year periods 1994–97 and 2004–
07, we observed a decrease in all non-traumatic LLAs. The inci-
dence of diabetic major LLAs per 103 diabetics per year decreased 
from 4.0 to 2.4, and in patients with peripheral vascular disease 
we observed a decrease in LLAs from 18 to 12 per 105 inhabitants 
per year. 5,915 consultations on diabetic subjects were conducted 
by the diabetic foot team during the period 1996–2006. From 1998 
to 2006, the rate of vascular procedures decreased in the non-dia-
betic population, and was unchanged in diabetic subjects. 
Interpretation      In  the  population  of  Trondheim  city  there 
appears to have been a reduction in the rate of vascular obstruc-
tive lower-limb disease between the two 3-year periods 1994–97 
and 2004–07. In our judgment, the decline in diabetic LLA also 
reflects better care of the diabetic foot. 
 
During the last decade, several studies have been published on 
the decreasing incidence of lower limb amputations (LLAs) 
in the diabetic population (Holstein et al. 2000, Calle-Pascual 
et al. 2001, van Houtum et al. 2004, Ekelinen et al. 2006, 
Trautner et al. 2007, Larsson et al. 2008, Canavan et al. 2008). 
Although the rate of LLA due to peripheral vascular disease 
in  the  non-diabetic  population  has  shown  a  similar  trend 
(Holstein et al. 2000, Calle-Pascual et al. 2001, Ekelinen et 
al. 2006), unchanged or even increased rates of non-diabetic 
LLA have been reported (Trautner et al. 2007, Canavan et al. 
2008). The reduction in the number of amputations in diabet-
ics has been attributed to better preventive care for the dia-
betic foot in general, and in particular to the establishment 
of multidisciplinary diabetic foot teams and implementation 
of the guidelines of the International Working Group on the 
Diabetic Foot (1999). In addition, most reports also attribute 
the falling rate of LLAs in diabetics to an increasing number 
of vascular interventions. However, only a few authors have 
actually registered the rate of revascularization in the diabetic 
and non-diabetic population (McCaslin et al. 2007). In the 
3-year period 1994–1996, the total number of primary LLAs 
in the city of Trondheim was 143. The incidence of primary 
LLA was 33 per 105 inhabitants per year, and diabetic amputa-
tions accounted for one-third of all primary LLAs (Witsø and 
Rønningen 2001). Partly as a consequence of this registration, 
a multidisciplinary diabetic foot team was established at St. 
Olav’s University Hospital in Trondheim in January 1996. The 
team has been an integrated part of the outpatient clinic of 
the Department of Orthopedic Surgery, and the main activity 
of the team is prevention and early treatment of diabetic foot 
ulcers. 
Here we report on the prospective registration of all primary 
LLAs and re-amputations performed on patients who were 
citizens of Trondheim in the period 2004–2007. Data from 
this registration were compared with data from the amputa-
tion registration in the city of Trondheim that was performed 
10 years earlier. We also registered the activity of the diabetic 
foot team during the decade 1996–2006, and the number of 
invasive  and  noninvasive  vascular  procedures  of  the  lower 
extremity  performed  in  diabetic  and  non-diabetic  subjects 
during the same period. 
Patients and methods
We have previously published data on LLA in Trondheim for 
the period 1994–1997 (Witsø and Rønningen 2001). From 
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limb amputations (LLAs) performed at St. Olav’s University 
Hospital. This is the only hospital in Trondheim, and all ampu-
tations are performed at the Department of Orthopedic Sur-
gery. As in 1994–97, we consecutively registered all primary 
amputations and re-amputations (see definitions). Auto-ampu-
tations were not included in the study. The registrations were 
based on 3 information sources: (1) consecutive registration of 
all LLAs, (2) operating theater records, including the operat-
ing theater at the outpatient clinic, and (3) hospital discharge 
data. 
The appropriate level for amputation was determined by 
clinical evaluation. Patients without a diagnosis of diabetes 
mellitus (DM) but with foot ulcer and peripheral neuropathy 
were screened by measurement of blood sugar and HbA1c. 
Demographic data
During the 2 study periods, 1994–97 and 2004–07, the aver-
age number of inhabitants in Trondheim was 143,300 and 
159,000, respectively. In both study periods, women consti-
tuted 51% of the population. In 1995 and 2005, respectively, 
the proportions of the total population that were in the fol-
lowing age groups were: 60–69 years, 8.0% and 7.8%; 70–79 
years, 7.1% and 5.8%; 80–89 years: 2.8% and 3.4%; and ≥ 90 
years, 0.4% and 0.5%, respectively.
The assessment of the diabetic population in Trondheim in 
1994–97 was based on the the Nord-Trøndelag Health Study 
1995–97 (HUNT 2). The 2 main counties of the middle-part of 
Norway are Sør- and Nord-Trøndelag. Trondheim is the larg-
est city in Sør-Trøndelag. The Nord-Trøndelag Health Study 
(HUNT) is one of the largest health studies ever performed 
(www.ntnu.no/hunt/english). HUNT 2 was the second health 
survey in Nord-Trøndelag, and the third (HUNT 3) was com-
pleted in June 2008. In the HUNT 2 study, 71% of the Nord-
Trøndelag population aged ≥ 20 years participated (Holmen et 
al. 2003). The highest degree of participation was in the female 
group aged 60–69 years (87%), and the lowest was in the male 
group aged 20–29 years (43%). The prevalence of DM was 
presented in the age groups 13–19, 20–29, 30–39, and so on 
up to 90+ years for men and women (Midthjell et al. 1999). In 
addition, a 0.15% prevalence of DM in children of < 13 years 
was based on the Norwegian Diabetes Register (Joner 1994). 
Data from Statistics Norway (www.ssb.no/english/) allowed 
us to make age groups (0–12, 13–19, 20–29, and so on up to 
90+ years) for females and males in Trondheim in 1995. We 
applied the age-specific prevalence of DM in men and women 
≥ 13 years in Nord-Trøndelag to the population of Trondheim 
that was ≥ 13 years, and a 0.15% prevalence of DM in indi-
viduals aged < 13 years in Trondheim. This resulted in an esti-
mate of 2,870 inhabitants with DM in Trondheim in 1995.
Stene et al. (2004) evaluated the changing prevalence of DM 
in Norway. In that paper the figures from 6 different Norwe-
gian studies in the period 1984–2001 were used to estimate 
the annual increase in the prevalence of DM as 1.4% in people 
aged ≥ 30 years. From the same studies, it was possible to 
estimate a sex-specific increase in the prevalence of diabetes 
of 0.4% for women and 2.5% for men. Thus, the prevalence 
of DM in Trondheim in 2004–2007 was estimated as follows. 
Briefly, in females in the 0- to 19-year age group, the preva-
lence of DM in 1994–97 was 0.24%, which we considered 
to be unchanged in 2004–07. In females ≥ 20 years of age, 
the prevalence in 1994–97 was 2.8%, which by 2004–07 had 
increased to 2.9%. In males in the 0- to 19-year age group, 
the prevalence of DM in 1994–97 was 0.30%, which we con-
sidered to be unchanged in 2004–07. In males ≥ 20 years, 
the prevalence in 1994–97 was 2.4%, which had increased to 
3.1% by 2004–07. These figures allow an estimate of 3,610 
subjects with DM in Trondheim in 2004–07. 
Activity of the diabetic foot team
The diabetic foot team of Trondheim was first and foremost a 
medical service for the inhabitants of Sør-Trøndelag County, 
most of whom are citizens of Trondheim. When the foot team 
was established in 1996, this team in collaboration with the 
Departments of Endocrinology, Vascular Surgery, and Derma-
tology, agreed on a policy whereby all patients with a dia-
betic foot ulcer would be referred to the foot team or directly 
to the Department of Orthopedic Surgery. Information about 
the foot team was sent to healthcare workers in the county, 
in particular to general practitioners and community nurses. 
Finally, meetings were arranged to inform people about the 
activity and policy of the team. The members of the team were 
nurses, podiatrists, orthopedic surgeons, orthotists, prosthe-
tists, and plaster technicians. At the first consultation, each 
patient received an information sheet for tuition and instruc-
tion. Screening for neuropathy was performed with a 10-gram 
Semmes-Weinstein monofilament and a 128 Hz tuning fork. 
Patients with a foot ulcer and no palpable pulses at the ankle 
level were immediately referred to the Department of Vascular 
Surgery. In addition to information and preventive care, the 
main treatment strategy was off-loading of neuropathic ulcers, 
vascular intervention in cases of neuroischemic ulcers, and 
radical debridement in cases of chronic osteomyelitis. 
Vascular interventions
The Norwegian vascular registry (NorKar) was established 
in 1995. Most departments performing vascular surgery in 
Norway report to this registry, and the completeness of data 
is at least 85% (Dahl et al. 2006). Based on the local database 
of NorKar at St. Olav’s University Hospital, we identified the 
annual number of femoropopliteal and femorodistal bypasses 
performed at St. Olav’s during the period 1998–2006. 
From 1998, all percutaneous vascular procedures performed 
at the Department of Radiology, St. Olav’s University Hos-
pital, were registered in a protocol. We identified all patients 
on  which  percutaneous  transluminal  angioplasties  (PTAs) 
had been performed on arteries distally to a. iliaca communis 
during the period 1998–2006. Only patients who were citizens 
of Trondheim were included.Acta Orthopaedica 2010; 81 (5): 737–744  739
Definitions
When  we  planned  the  present  study,  we  decided  that  the 
overall design should be as similar as possible to that of the 
study from 1994–1997. In that study, the definitions of pri-
mary amputation and re-amputation were based on a paper by 
Larson and Apelqvist (1995). 
Primary  amputation:  the  first  amputation  procedure  in 
a sequence until a final outcome (healed or death). Conse-  Conse-
quently, primary amputation is included the following: ini-
tial amputation, first amputation, first-event amputation, new 
amputation, and second leg amputation—i.e. all amputations 
except re-amputations.
Re-amputation: amputation of a limb with an unhealed pre-
vious amputation by cutting through bone or a joint.
Major amputation: amputation through or above the ankle 
joint.
Minor amputation: Amputation below the ankle joint.
A diabetic subject: a person treated for high blood sugar 
using diet, oral antidiabetics, or insulin.
Diabetes mellitus types I and II: patients were classified as 
having DM type I if diabetes was diagnosed at the age of < 40 
years and if insulin treatment was started less than 6 months 
after diagnosis. 
A diabetic foot ulcer: infection, ulceration, destruction of 
deep  tissue  of  the  foot  associated  with  neuropathy  and/or 
peripheral arterial disease of the lower extremity of people 
with DM.
Statistics
If  not  otherwise  stated,  the  results  are  presented  as  arith-
metic mean with dispersion (as total range) in parentheses. 
Incidence rates were analyzed using Poisson regression with 
decade as covariate, using Stata software version 10.0. Esti-
mates are given with 95% confidence intervals (CIs) where 
relevant. Wilson (score) confidence intervals for proportions 
were computed. Two-sided p-values of < 0.05 were consid-
ered significant. 
Results
During the 2 separate study periods (1994–1997 and 2004–
2007),  33  and  24  primary  LLAs/105  inhabitants/year  were 
performed in Trondheim (p = 0.007). The mean ages of the 
amputees were 73 (21–98) years in 1994–97 and 74 (33–93) 
years in 2004–07. Of the amputees, 67/143 (47%, CI: 39–55) 
were females in 1994–97 and 49/113 (43%, CI: 35–53) were 
females in 2004–07.
 We identified 3 diagnostic groups: (a) peripheral vascular 
disease (PVD) amputations, (b) diabetic amputations, and (c) 
other LLAs (this group included cases of trauma, invasive soft 
tissue infections, cold injury, and malignant tumors, amongst 
others). Diabetic LLAs accounted for one-third of the ampu-
tations in both periods. We observed a 40% reduction in the 
annual rate of major diabetic LLAs/103 diabetics. However, 
we observed a similar reduction in the rate of PVD LLAs 
(Table 1). Consequently, in both periods the incidence of pri-
mary LLA in diabetic subjects was approximately 30 times 
higher  than  the  incidence  of  primary  LLA  in  non-diabetic 
subjects. In both periods, patients with DM were amputated 
at a younger age compared to patients with PVD: 71 (42–97) 
years vs. 78 (58–98) years in 1994–97, and 73 (34–93) years 
vs. 79 (47–93) years in 2004–2007 (p = 0.001 and p = 0.03, 
respectively; Student’s t-test). 
The relative rate of major LLA/all LLA was similar in the 
two  study  periods:  118/143  (83%,  CI:  75–88)  in  1994–97 
and 92/113 (81%, CI: 73–88) in 2004–07. However, the inci-
dence of primary transtibial amputations in patients with DM 
decreased from 3.7/105 inhabitants/year in 1994–97 to 1.7/105 
inhabitants/year in 2004–07. The incidence of primary trans-
femoral  amputation  in  patients  with  PVD  decreased  from 
6.8/105 inhabitants/year in 1994–97 to 1.7/105 inhabitants/year 
in 2004–07. In both periods, major LLAs were more common 
in patients with PVD than in patients with DM (Table 2). 
More than 85% of all major LLAs in both periods were per-
formed at age ≥ 70 years in females and ≥ 60 years in males 
(Table 3). The rate of re-amputation was 22/143 (15%, CI: 
Table 1. Primary LLAs performed on citizens of Trondheim in 1994–1997 and 2004–2007
  1994-01-01   2004-04-01  p-value for
  to   to  difference
  1997-01-01  2007-04-01
Inhabitants   143,000  159,000 
Inhabitants with diabetes mellitus   2,870  3,610 
All primary LLAs  143  113 
Diabetic primary LLAs  47  38 
Primary LLAs from peripheral 
   vascular disease (PVD)  76  55 
Other primary LLAs   20  20 
Primary LLAs/105 inhabitants/year   33  24  0.007
Diabetic primary LLAs/105 inhabitants/year  11  8 
Diabetic primary LLAs/103 diabetics/year   5.5  3.5  0.04 
Major diabetic primary LLAs/103 diabetics/year   4.0  2.4  0.06 
Primary LLAs from PVD/105/year  18  12  0.02740  Acta Orthopaedica 2010; 81 (5): 737–744
10–22) in 1994–97 and 21/113 (19%, CI: 12–27) in 2004–07. 
The rates of re-amputation at the partial foot, transtibial, and 
knee disarticulation amputation levels in patients with DM 
and PVD are presented in Table 4. 
779 diabetic subjects were referred to the diabetic foot team 
in Trondheim over the period 1996–2007. 5,915 consultations 
were held and, except for the first year, the activity of the team 
was stable with mean 600 (502–666) consultations per year. 
5/779 patients (1%) had DM secondary to pancreatic trauma, 
182/779 patients (23%) had DM of type I and 592/779 (76%) 
had DM of type II. In patients with type-I and type-II DM, 
peripheral neuropathy was registered in 115/182 (63%, CI: 
56–70) and 514/592 (87%, CI: 84–89) patients. At the first 
consultation, 41/182 (23%, CI: 17–29) patients with type-I 
DM had a diabetic foot ulcer, as compared to 223/592 (38%, 
CI: 34–42) patients with type-II DM. Of the 779 patients who 
were referred to the diabetic foot team, approximately 460 
were citizens of Trondheim, and 160 (35%) of these patients 
were diagnosed as having either a neuropathic or a neuroisch-
emic foot ulcer at the first consultation. 
During the period 1998–2006, the rate of femoropopliteal 
and femorodistal bypasses and the rate of PTA performed on 
arteries distal to a. iliaca communis decreased in patients with 
PVD. The rate of vascular procedures was unchanged in dia-
betic subjects (Table 5).
Discussion
During the decade 1994–97 to 2004–07, the incidence of pri-
mary LLA declined in the city of Trondheim in both main 
Table 2. All primary LLAs performed on citizens of Trondheim in 1994–97 and 2004–07 
due to diabetes mellitus (DM), peripheral vascular disease (PVD), or for other reasons 
(such as trauma, infection, or malignant tumors) 
  LLA due to DM  LLA due to PVD  LLA for other reasons 
  1994–97   2004–07  1994–97   2004–07  1994–97   2004–07
Partial foot amputation  13  12  3  3  9  6
Ankle disarticulation  0  0  0  0  1  1
Transtibial amputation  16  8  12  17  3  5
Knee disarticulation  14  12  31  27  3  1
Transfemoral amputation  4  6  29  8  3  5
Hip disarticulation  0  0  1  0  1  2
Major LLA  34  26  73  52
All LLA  47  38  76  55
Ratio  0.7  0.7  1.0  1.0
95% CI  0.6–0.8  0.5–0.8  0.9–1.0  0.9–1.0
Table  3.  Breakdown  of  major  LLA  in  Trondheim  in  1994–97  and 
2004–07 in terms of patient age and sex
Age  < 60 years  60–69 years  ≥ 70 years
1994–97  Male  5  16  41
  Female  3  4  49
2004–07  Male  8  7  37
  Female  1  2  37
Table 4. Re-amputations at the partial foot, transtibial, and knee disarticulation level in 
patients with diabetes mellitus (DM) and peripheral vascular disease (PVD)
  1994–1997  2004–2007
  Re-amputations / total  Re-amputations / total
Level  (rate, CI)  (rate, CI)
Partial foot amputation 
  Patients with DM  5/13 (0.4, CI: 0.2–0.6)   3/12 (0.3, CI: 0.1–0.5)
  Patients with PVD  2/3   (0.7, CI: 0.2–0.9)  1/3   (0.3, CI: 0.1–0.8)
Transtibial amputation 
  Patients with DM  3/16 (0.2, CI: 0.1–0.4)  3/8   (0.4, CI: 0.1–0.7)
  Patients with PVD  2/12 (0.2, CI: 0.0–0.4)  3/17 (0.2, CI: 0.1–0.4)
Knee disarticulation 
  Patients with DM  1/14 (0.1, CI: 0.0–0.3)  4/12 (0.3, CI: 0.1–0.6)
  Patients with PVD  5/31 (0.2, CI: 0.1–0.3)  5/27 (0.2, CI: 0.1–0.4)Acta Orthopaedica 2010; 81 (5): 737–744  741
diagnostic  groups,  i.e.  patients  with  diabetes  mellitus  and 
patients with peripheral vascular disease.
The completeness of the patient material is important in a 
registry (Larsson et al. 2008). Studies on the incidence of LLA 
have mainly been retrospective and based on hospital regis-
ters; not all studies have included all amputation levels and 
some studies have not distinguished between first amputation, 
primary amputation, and re-amputation, and, finally, not all 
studies have had a clear definition of DM (Lázlo et al. 1999, 
Mayfield et al. 2000, Calle-Pascual et al. 2001, Eskelinen et 
al. 2001, Trautner et al. 2001, Romagnoli et al. 2003, Eke-
linen et al. 2004, Carmona et al. 2005, Harding 2005, Eke-
linen et al. 2006, McCaslin et al. 2007). The uncertainty of 
the prevalence of DM in the study population is a particular 
problem related to registration of diabetic LLA (van Houtum 
and Lavery 1997). 
In  the  present  study  and  in  the  study  from  1994–1997 
(Witsø and Rønningen 2001), similar methods of patient reg-
istration were employed. In theory, inhabitants of Trondheim 
could have been amputated at other hospitals outside Trond-
heim. During the last 20 years, we have been aware of a few 
cases of trauma and malignant tumors (osteosarcoma) when 
inhabitants of Trondheim were amputated at hospitals outside 
Trondheim. However, in cases of amputation due to DM and 
PVD, this should be extremely rare. 
There is wide variation in how data from studies on the inci-
dence of LLA in general, and on diabetic LLA in particular, 
are presented. In incidence reports, the denominator might 
either be the total population or the number of diabetic sub-
jects. The numerator is presented as the total number of ampu-
tations (including re-amputations), or only the first or primary 
amputation. Major amputation may be defined as amputations 
proximal to the tarsometatarsal joint, proximal to the subtalar 
joint, or proximal to the ankle joint (Larsson et al. 1995, Hol-
stein 2000, Calla Pasqual 2001, Eskelin 2006, Canavan 2008, 
Larsson 2008). In both study periods we registered primary 
LLA, and primary LLA (either all or major) was employed 
as  the  numerator  in  incidence  estimates.  In  primary  LLA, 
we included all amputations except re-amputations. Primary 
amputation was chosen as a variable since this allowed us to 
compare amputation rates in the 2 study periods. Hence, data 
from the present study cannot readily be compared with other 
amputation studies on first or initial LLA, and studies where 
all amputations also include re-amputation (The Global Lower 
Extremity Amputation Study Group 2000, Calle-Pascual et 
al. 2001, Canavan 2008, Johannesson et al. 2009). However, 
when the data from our study were compared with those from 
other relevant studies, we found that the incidence of all LLAs 
and diabetic amputations had fallen from intermediate rates 
in 1997–1997 to low rates in 2004–2007 (Jeffcoate and van 
Houtum 2004). 
Contrary to other studies, the falling incidence of diabetic 
and peripheral vascular disease LLA in Trondheim cannot be 
attributed to an increased number of vascular interventions 
Table 5. Annual numbers of invasive and noninvasive vascular procedures performed in 
diabetic and non-diabetic subjects in Trondheim, 1998–2006
A  B  C  D  E  F  G
1998  3,074  142,704  8  18    9  40
1999  3,146  144,041  8  14    8  46
2000  3,219  145,640  9  11  10  48
2001  3,293  146,873  7    9    4  42
2002  3,370  148,038  9  15  10  47
2003  3,448  149,251  7  11  15  39
2004  3,528  150,823  8  10  12  30
2005  3,610  152,551  9    7  13  30
2006  3,694  154,919  9    6  12  20
Relative change in incidence per year a  –0.013  –0.107  0.046  –0.080
Estimate (upper 95% CL)     –0.096  –0.174  –0.034   –0.117
Estimate (lower 95% CL)      0.078  –0.036  0.133  –0.041
p-value      0.8  0.004  0.3  < 0.001 
a for example, –0.013 means a relative reduction of 1.3% per year. Computed as
  exp(beta) – 1, where beta is the coefficient for year in Poisson regression with the 
  relevant population as exposure variable.
A  Year 
B  Diabetic population, estimates based on 2,870 and 3,610 diabetics in 1995 and 2005, 
assuming a constant growth rate. 
C  Non-diabetic population, total population from Statistics Norway (www.ssb.no/english/) 
minus the estimated diabetic population in the preceding column
D  Femoropopliteal and femorodistal bypasses in diabetic subjects
E  Femoropo  pliteal and femorodistal bypasses non-diabetic subjects 
F  PTA in diabetic subjects
G    PTA in non-diabetic subjects742  Acta Orthopaedica 2010; 81 (5): 737–744
(Larson  et  al.  1995,  Holstein  et  al.  2000,  Eskelinen  2004, 
Eskelinen et al. 2006, Larsson et al. 2008). In non-diabetic 
inhabitants of Trondheim, there was even a decline in the rate 
of invasive and non-invasive vascular procedures in the lower 
extremity during the period 1998–2006. The annual change 
in incidence shown in Table 5 could have been influenzed by 
changes in sex or age distribution. However, the sex distri-
bution in the 2 study periods was stable at 51% females and 
49% males, and there were only slight changes in age distri-
bution, as described under Demographic data. The proportion 
of patients aged 80 years and above increased from 3.3% to 
3.9%, and the proportion aged 60–79 decreased from 15.1% 
to 13.6%. The relative change per year in incidence rates in 
patients with PVD (Table 5), correspond to a reduction of the 
rate of femoropopliteal and femorodistal bypasses and PTA 
of approximately 50% from 1998 to 2006. Thus, we consider 
the possible influence of change in age distribution to be neg-
ligible.
The results of 2 health survey studies from the middle-part 
of Norway showed a strong decline in mortality from coronary 
heart disease between the periods 1984–86 and 1995–97 (Dale 
et al. 2008). Although the decline was observed in people with 
and without diabetes, the 2-fold higher mortality rate from 
coronary heart disease in diabetics did not change over time. 
During the past 3 decades, a reduced incidence of coronary 
heart  disease  has  been  observed  in  other  Nordic  countries 
(Abildstrom et al. 2003, Laatikainen et al 2005). This decrease 
has been attributed to reduced exposure to risk factors such 
as elevated serum cholesterol, smoking, and elevated blood 
pressure. In contrast, an unfavorable trend in the incidence of 
coronary heart disease in young adults in the USA has been 
explained  by  considerable  increases  in  abdominal  obesity, 
diabetes, and hypertension (Ford and Capewell 2007). The 
observed decrease in all non-traumatic LLA in our study may 
therefore have been a result of improvement in lifestyle in 
general and a reduced prevalence of vascular obstructive dis-
ease. The atherosclerotic lesions are located more distally in 
the lower extremity in diabetic subjects than in non-diabetic 
subjects (International Working Group on the Diabetic Foot 
1999). Consequently, a reduced prevalence of atherosclerosis 
in the diabetic and non-diabetic population is in accordance 
with the 54% reduction in transtibial amputations seen in dia-
betic subjects, and the 75% reduction in transfemoral amputa-
tions in non-diabetic subjects. We speculated whether a more 
restrictive  policy  regarding  LLA  in  the  very  elderly  could 
explain the observed decline in LLA. However, the mean age 
of PVD amputees was similar in the 2 study periods (78 years 
and 79 years). 
A diabetic foot ulcer is the major risk factor for LLA in 
diabetic subjects (Margolis et al. 2005). Prevention and early 
treatment of diabetic foot ulcers can reduce the amputation 
rate by 50%, and the establishment of a multidisciplinary foot 
care team is a cornerstone in the management and prevention 
of diabetic foot ulcers (Apelqvist et al. 2008). In a study from 
Germany lasting over 15 years (1990–2005), the estimated 
reduction in diabetic LLA above toe level was 37%, while the 
incidence rates in the non-diabetic population did not change. 
The observed decline in diabetic LLA was explained by better 
care in patients with diabetic foot pathology (Trautner et al. 
2007). Although diabetic subjects are influenced by the same 
positive predictors as non-diabetic subjects, we partly attri-
bute the decline in diabetic amputations in Trondheim to the 
activity of the diabetic foot team. In accordance with previous 
reports, we have observed that patients with DM of type II 
are particularly at risk (Morris et al. 1998). Patients with DM 
of type II have an increased risk of diabetic foot ulcers than 
patients with DM of type I. To avoid ulcers in these patients, 
collaboration with primary healthcare in general and general 
practitioners in particular, is important. 
In the period 2004–2007, the rate of re-amputations was 
rather high in transtibial and knee disarticulation amputees. 
Although we did not observe a statistically significant increase 
compared to the period 1994–1997, a 0.3 rate of re-amputa-
tions after knee disarticulation in patients with DM is high. 
A  similar  regime  for  antibiotic  prophylaxis  was  employed 
during both study periods. In 2004–2007, the amputation level 
was mainly determined by clinical evaluation. The reported 
re-amputation rate highlights the need for additional, noninva-
sive methods for assessment of the amputation level. In most 
cases of re-amputation after knee disarticulation we observed 
impaired  circulation  in  the  anterior  flap,  underscoring  the 
need for a well-circulated posterior flap. Compared to other 
studies on LLA in Scandinavia, knee disarticulation is a more 
common amputation level in Trondheim (Larsson et al. 2008, 
Johannesson et al. 2009). At our clinic, we have a tradition of 
performing knee disarticulation (if possible) instead of trans-
femoral amputation. Such a strategy could of course result in 
too many re-amputations at the knee level, particularly if non- non-
invasive methods for the assessment of arterial circulation are 
employed. 
The present study has some limitations. First, the numbers 
of diabetics were not known accurately, and have been esti-
mated. We have carefully explained the background to these 
estimates, and we consider them to be precise enough for our 
calculations. Secondly, due to a probable decrease in athero- due to a probable decrease in athero-
sclerosis and obstructive vascular diseases in the study popu-
lation, we should have been able to observe a relative decline 
in the rate of diabetic LLA preceded by neuroischemic foot 
ulcers. The 1994–1997 study was not designed for such an 
analysis. Finally, we are unable to estimate the relative influ-
ence of the activity of the diabetic foot team and the general 
improvement  in  public  health  on  the  reduction  in  diabetic 
LLA.
In conclusion, in the city of Trondheim the rates of both dia-
betic- and PVD-associated primary LLA have decreased over 
the last decade. As in other studies, our results may reflect 
an improved quality of prevention and treatment of diabetic 
foot ulcers. In contrast to other studies, however, our results Acta Orthopaedica 2010; 81 (5): 737–744  743
cannot be attributed to an increased rate of vascular interven-
tion. To our knowledge, our study is one of the first reports of 
a reduced incidence of all non-traumatic LLA—probably due 
to a general improvement in public health in general and a 
reduced incidence of vascular obstructive disease in particular. 
Since diabetic subjects are still at 30 times higher risk of being 
amputated compared to non-diabetic subjects, a further reduc-
tion in the rate of diabetic LLA should be possible.
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